☆ 4.8 Article

Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly

CELL REPORTS (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Accelerated waning of the humoral response to COVID-19 vaccines in obesity

Agatha C. van der Klaauw et al.

Summary: Obesity is associated with an increased risk of severe COVID-19 infection and mortality. COVID-19 vaccines may be less effective in individuals with obesity. A study in Scotland found that vaccinated individuals with severe obesity were more likely to experience hospitalization or death from COVID-19. Another study found that individuals with severe obesity had lower levels of neutralizing antibodies after vaccination compared to individuals with a normal BMI, and the decline in antibody levels was faster in people with severe obesity.

NATURE MEDICINE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals

Katlyn Lederer et al.

Summary: This study compared the immune responses to SARS-CoV-2 mRNA vaccines in healthy individuals and kidney transplant recipients by analyzing lymph nodes. The results showed that kidney transplant recipients had significantly impaired immune responses, including reduced GC B cell responses, hindered T follicular helper cell function, and decreased memory B cell and neutralizing antibody responses. They also had reduced frequencies of SARS-CoV-2-specific CD4 and CD8 T cells. These findings suggest impaired GC-derived immunity in immunocompromised individuals following mRNA vaccination.

CELL (2022)

Add to Collection

Article Immunology

Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers

Wenzhi Song et al.

Summary: Tbet(+)CD11c(+) B cells are a specific subset of B cells that arise during immune challenges, aging, and autoimmune processes. T follicular helper (Tfh) cells were found to drive the generation of Tbet(+)CD11c(+) B cells, which develop prior to germinal center formation and have distinct phenotypic and transcriptional profiles from germinal center B cells. Fate tracking revealed that the development of most Tbet(+)CD11c(+) B cells is independent of germinal center entry and cell-intrinsic Bcl6 expression. These cells form a competitive memory subset in the marginal zone and contribute to efficient antibody production and secondary germinal center seeding upon rechallenge.

IMMUNITY (2022)

Add to Collection

Article Immunology

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

Mark A. Brockman et al.

Summary: Humoral responses to COVID-19 mRNA vaccines are significantly weaker in older adults, and decline over time. Age is a significant predictor of antibody concentration and virus neutralizing activity, even after adjusting for participant demographics.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Letter Medicine, General & Internal

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

Wanwisa Dejnirattisai et al.

LANCET (2022)

Add to Collection

Article Multidisciplinary Sciences

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Bo Meng et al.

Summary: The Omicron variant of SARS-CoV-2 has a higher affinity for ACE2 and can evade neutralizing antibodies more effectively compared to the Delta variant. A third dose of mRNA vaccine can provide enhanced protection. Omicron has lower replication in lung and gut cells and less efficiently cleaves its spike protein compared to Delta.

NATURE (2022)

Add to Collection

Article Medicine, General & Internal

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

Roos S. G. Sablerolles et al.

Summary: This study investigated the immunogenicity and reactogenicity of a homologous or heterologous booster in healthcare workers who had received a single-shot Ad26.COV2.S vaccine. The results showed that booster vaccinations increased the levels of S-specific binding antibodies, neutralizing antibodies, and T-cell responses compared to a single Ad26.COV2.S vaccination. Boosters containing mRNA-based vaccines induced significantly higher levels of binding antibodies than homologous boosters. The mRNA-1273 booster was the most immunogenic but had higher reactogenicity compared to the BNT162b2 and Ad26.COV2.S boosters. Local and systemic reactions were generally mild to moderate in the first 2 days after booster administration.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Letter Medicine, General & Internal

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans

Florian B. Mayr et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

Catherine J. Reynolds et al.

Summary: The study found that the initial strain of SARS-CoV-2 infection's impact on downstream immunity to heterologous variants of concern (VOCs) is unknown. After three antigen exposures, neutralization potency against different VOCs changed, and serology poorly predicted neutralizing immunity. Heterologous combinations of spike encountered during infection and vaccination shape subsequent cross-protection against VOCs.

SCIENCE (2022)

Add to Collection

Article Medicine, General & Internal

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants

Ruediger Gross et al.

Summary: According to a study on a cohort of individuals who received heterologous ChAdOx1 nCoV-19 BNT162b2 vaccination, the regimen induced potent humoral and cellular immune responses, with strong neutralization of the most prevalent SARS-CoV-2 variants. The results suggest that this heterologous vaccination regimen is at least as immunogenic and protective as homologous vaccinations and also offers protection against current variants of concern.

EBIOMEDICINE (2022)

Add to Collection

Article Immunology

In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue

Zhi Li et al.

Summary: This study used photoconversion to label tumor-infiltrating lymphocytes and found that TCF-1(+) T cells migrate continuously between the tumor and draining lymphoid tissue. The study also revealed the transcriptional characteristics of CD8 T cells in the tumor and their dynamic changes in retention and egress.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Add to Collection

Article Immunology

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

Francis Mwimanzi et al.

Summary: One month after receiving a third dose of the COVID-19 vaccine, older adults showed comparable immune responses to both ancestral and omicron variants of the virus, compared to younger adults. These findings highlight the benefits of third vaccine doses, especially for older adults.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Infectious Diseases

COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study

Cristina Menni et al.

Summary: This study aimed to investigate the effectiveness and waning of COVID-19 primary vaccine series, as well as the safety and effectiveness of booster doses. The results showed that vaccine effectiveness decreased after the second dose, but booster doses restored effectiveness. However, heterologous booster regimens had more systemic side-effects.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years

Ronen Arbel et al.

Summary: A retrospective analysis of data from Israel shows that a second booster shot of BNT162b2 in individuals aged 60 and over significantly reduces hospitalizations and deaths due to COVID-19.

NATURE MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Cross-tissue immune cell analysis reveals tissue-specific features in humans

C. Dominguez Conde et al.

Summary: This study investigated immune cells in 16 human tissues using single-cell RNA sequencing and VDJ sequencing, revealing the distribution of finely phenotyped immune cell types across tissues and uncovering tissue-specific features and clonal architecture of T and B cells.

SCIENCE (2022)

Add to Collection

Article Medicine, General & Internal

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis

Wing Ying Au et al.

Summary: The study evaluates the effectiveness of heterologous and homologous COVID-19 vaccine regimens in preventing COVID-19 infections, hospital admissions, and death. Results show that a three-dose mRNA vaccine regimen is most effective against asymptomatic and symptomatic COVID-19 infections, while a homologous two-dose mRNA regimen is highly effective in preventing severe COVID-19 infections.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Add to Collection

Article Medicine, General & Internal

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies

Alexandra J. Spencer et al.

Summary: This study describes the generation and preclinical assessment of a vaccine targeting Beta VoC (B.1.351), which shows immunogenicity after a single dose and produces antibody responses to other variants as a booster, along with a strong T cell response.

EBIOMEDICINE (2022)

Add to Collection

Article Immunology

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination

Yu Gao et al.

Summary: Many immunocompromised patients have suboptimal cell-mediated immunity after SARS-CoV-2 mRNA vaccination, particularly solid-organ transplant and chronic lymphocytic leukemia patients. However, individuals with X-linked agammaglobulinemia (XLA) showed highly functional spike-specific T cell responses. The study also revealed a broad functional spectrum of spike-specific CD4(+) and CD8(+) T cells in healthy individuals and XLA patients after mRNA vaccination.

IMMUNITY (2022)

Add to Collection

Article Cell Biology

The memory B cell response to influenza vaccination is impaired in older persons

Alice R. Burton et al.

Summary: This study reveals defects in the human germinal center reaction and memory B cell response following influenza vaccination in elderly individuals.

CELL REPORTS (2022)

Add to Collection

Article Immunology

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2

Cyril Planchais et al.

Summary: This study reveals the contribution of memory B cells and antibodies targeting the SARS-CoV-2 spike protein to long-term immune protection against severe COVID-19. It also identifies potent IgA antibodies that can neutralize the virus, highlighting their potential for COVID-19 prevention and treatment.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Add to Collection

Letter Biochemical Research Methods

VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2

Mikhail Goncharov et al.

NATURE METHODS (2022)

Add to Collection

Article Multidisciplinary Sciences

Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers

Steven A. Kemp et al.

Summary: Studies have shown transmission of SARS-CoV-2 among vaccinated healthcare workers, highlighting the need for ongoing infection control measures. The research also introduces a novel approach to identifying transmissions that is scalable and rapid without the need for an infection control infrastructure.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Cell Biology

Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination

William S. Foster et al.

Summary: This study demonstrates the critical role of germinal centers induced by the ChAdOx1 nCoV-19 vaccine in humoral immunity, with T follicular helper (Tfh) cells playing an important role and exhibiting pluripotent memory.

CELL REPORTS MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa

Adam Abdullahi et al.

Summary: Real-world data on vaccine-elicited neutralising antibody responses for two-dose AZD1222 in African populations are limited. This study assessed the seroprevalence and neutralizing antibody levels in Nigerian healthcare workers and Ghanaian community members before and after vaccination. The results showed that AZD1222 is immunogenic in these two populations, but there is a waning effect on neutralizing antibodies over time, especially in individuals who have not been previously infected.

NATURE COMMUNICATIONS (2022)

Add to Collection

Review Cell Biology

Count on us: T cells in SARS-CoV-2 infection and vaccination

Katherine Kedzierska et al.

Summary: This article discusses epitope-specific CD8(+) and CD4(+) T cell responses to SARS-CoV-2 infection and vaccination, their persistence in long-term memory, and their role in limiting disease severity.

CELL REPORTS MEDICINE (2022)

Add to Collection

Article Medicine, Research & Experimental

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies

Alessio Mazzoni et al.

Summary: This study longitudinally evaluated the duration of SARS-CoV-2 immunological memory and found that memory cells can still be detected up to 8 months after vaccination, while antibody levels decline significantly. A booster dose was effective in reactivating immunity in naive individuals but had no effect in previously infected individuals. Unvaccinated individuals showed a similar decline in cellular and humoral immunity to SARS-CoV-2 up to 1 year following natural infection.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection

Article Medicine, Research & Experimental

SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies

Anna Jeffery-Smith et al.

Summary: Memory B cells specific to SARS-CoV-2 can persist beyond the loss of neutralizing antibodies and provide a reserve immunity. However, activated MBCs are expanded in the elderly, indicating ongoing antigenic stimulation or inflammation. Some individuals who have lost neutralizing antibodies still exhibit MBCs and functional immune response to SARS-CoV-2, but this is significantly impaired in the elderly.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Alasdair P S Munro et al.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof et al.

Summary: This study aimed to assess the overall and variant-specific effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19-related hospital admissions among members of a healthcare system in California. The effectiveness of the vaccine remained high against hospital admissions even up to 6 months after full vaccination, despite a decline in effectiveness against SARS-CoV-2 infections over time, which was likely due to waning immunity rather than the delta variant escaping vaccine protection.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier et al.

Summary: The B.1.1.7 variant of SARS-CoV-2 exhibited reduced neutralization by vaccines and antibodies from recovered COVID-19 patients, with a more substantial loss seen when introducing the E484K mutation. This mutation poses a threat to the efficacy of the BNT162b2 vaccine.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp et al.

Summary: Chronic infection with SARS-CoV-2 can lead to viral evolution and increased resistance to neutralizing antibodies in immunosuppressed individuals treated with convalescent plasma. During convalescent plasma therapy, there were significant shifts in the viral population structure and sensitivity, suggesting strong selection pressure on the virus during treatment.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India

Mahesh S. Dhar et al.

Summary: Delhi experienced multiple severe outbreaks in 2020, reaching a seropositivity rate of >50% by 2021. The Delta variant's high transmissibility and immune evasion led to a surge in cases in Delhi.

SCIENCE (2021)

Add to Collection

Editorial Material Multidisciplinary Sciences

COVID-19 vaccine breakthrough infections

Ravindra K. Gupta et al.

SCIENCE (2021)

Add to Collection

Article Cell Biology

Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans

Henry J. Sutton et al.

Summary: Using single-cell RNA sequencing, researchers explored the diversity of human B cells in healthy individuals and those exposed to malaria, identifying two distinct lineages with atypical B cells being part of the alternative lineage. Upon malaria vaccination, the alternative lineage cells respond to initial immunization and booster doses, but develop an atypical phenotype with repeated boosts, indicating that atypical cells are a normal component of healthy immune responses.

CELL REPORTS (2021)

Add to Collection

Article Multidisciplinary Sciences

scCODA is a Bayesian model for compositional single-cell data analysis

M. Buettner et al.

Summary: scCODA is a Bayesian model that effectively detects cell type changes, addressing the difficulties in single-cell experiments. It demonstrates excellent performance, reliably controls false discoveries, and identifies experimentally verified cell type changes missed in original analyses.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Biology

Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans

Danika L. Hill et al.

Summary: Research has shown that the formation of circulating T follicular helper cells is associated with high-titre antibody responses following influenza vaccination, but this differentiation is impaired in older people. Strategies to temporarily suppress inflammation at vaccination may enhance antibody generation in older individuals.

ELIFE (2021)

Add to Collection

Article Biology

TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs

Koshlan Mayer-Blackwell et al.

Summary: By using meta-clonotypes, researchers can accurately quantify functionally similar TCRs, and identified antigen-specific meta-clonotypes with strong evidence in the TCR data from COVID-19 patients. This approach showed that meta-clonotypes targeting specific epitopes were more frequently detected in bulk repertoires compared to exact amino acid matches, demonstrating the potential utility of meta-clonotypes as antigen-specific features for biomarker development.

ELIFE (2021)

Add to Collection

Article Medicine, General & Internal

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

Victoria Jane Hall et al.

Summary: The study aimed to determine the factors associated with vaccine coverage for two COVID-19 vaccines in the UK and to document the vaccine effectiveness of the BNT162b2 mRNA vaccine among healthcare workers. Results showed that the vaccine can prevent both symptomatic and asymptomatic infections in working-age adults, with a vaccine effectiveness of 70% after the first dose and 85% after the second dose.

LANCET (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

S. A. Madhi et al.

Summary: The ChAdOx1 nCoV-19 vaccine did not provide significant protection against mild-to-moderate Covid-19 caused by the B.1.351 variant, with an efficacy of 10.4%. The incidence of serious adverse events was balanced between the vaccine and placebo groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Jamie Lopez Bernal et al.

Summary: This study estimated the real-world effectiveness of Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed COVID-19 symptoms, hospital admissions, and deaths. The vaccines showed significant reduction in symptomatic COVID-19 among older adults and further protection against severe disease. Both vaccines demonstrated similar effects and protection was maintained for over 6 weeks.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Immunology

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion

Isabella A. T. M. Ferreira et al.

Summary: The SARS-CoV-2 B.1.617 variant from India with key mutations L452R and E484Q shows reduced sensitivity to neutralizing antibodies elicited by the BNT162b2 mRNA vaccine, similar to the effect of L452R or E484Q mutations alone.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Letter Medicine, General & Internal

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1

Madhumita Shrotri et al.

LANCET (2021)

Add to Collection

Letter Medicine, General & Internal

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC

Emma C. Wall et al.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia et al.

Summary: To date, there are no immunological data on COVID-19 heterologous vaccination schedules in humans. This study evaluated the immunogenicity and reactogenicity of administering BNT162b2 as a second dose in individuals primed with ChAdOx1-S. The results showed that BNT162b2 induced a robust immune response in individuals prime vaccinated with ChAdOx1-S, with an acceptable and manageable reactogenicity profile.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Dami A. Collier et al.

Summary: Elderly individuals, especially those above eighty, show lower immune responses and neutralization abilities against variants of concern after the first vaccine dose, but this improves after the second dose. They have higher frequencies of spike-specific memory B cells but reduced somatic hypermutation of class-switched cells. Production of interferon-gamma and interleukin-2 by SARS-CoV-2 spike-specific T cells is lower in older participants, predominantly by CD4 T cells.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Systems vaccinology of the BNT162b2 mRNA vaccine in humans

Prabhu S. Arunachalam et al.

Summary: The study found that vaccination with the Pfizer-BioNTech mRNA vaccine can induce immune responses against neutralizing antibodies and CD4, CD8 T cells of SARS-CoV-2. Booster vaccines can significantly enhance innate immune responses, and different innate pathways associated with CD8 T cells and neutralizing antibodies have been identified.

NATURE (2021)

Add to Collection

Article Immunology

mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects

Dorit Fabricius et al.

Summary: The study found that mRNA vaccines induced stronger cellular and serological immune responses, including neutralizing capacity against VOCs, compared to ChAdOx1-nCoV-19. Booster immunizations with mRNA vaccines triggered strong and broadly neutralizing antibody and IFN-gamma responses in 100% of vaccinated individuals, especially for those with prior COVID-19 or ChAdOx1-nCoV-19 vaccination.

VACCINES (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Petra Mlcochova et al.

Summary: The B.1.617.2 (Delta) variant of SARS-CoV-2 has lower sensitivity to antibodies and higher replication efficiency compared to other lineages, which may contribute to its dominance and reduced vaccine effectiveness, highlighting the need for continued infection control measures post-vaccination.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

UCell: Robust and scalable single-cell gene signature scoring

Massimo Andreatta et al.

Summary: UCell is an R package designed for evaluating gene signatures in single-cell datasets. It offers robust signature scores based on the Mann-Whitney U statistic, requiring less computing time and memory compared to other methods. UCell can handle large datasets in minutes and can interact directly with Seurat objects.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Add to Collection

Article Biochemical Research Methods

BBKNN: fast batch alignment of single cell transcriptomes

Krzysztof Polanski et al.

BIOINFORMATICS (2020)

Add to Collection

Review Immunology

Age-Associated B Cells

Michael P. Cancro

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Add to Collection

Article Multidisciplinary Sciences

A cell atlas of human thymic development defines T cell repertoire formation

Jong-Eun Park et al.

SCIENCE (2020)

Add to Collection

Article Biochemical Research Methods

Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes

Haynes Heaton et al.

NATURE METHODS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition

Emanuela Pasciuto et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A thermostable, closed SARS-CoV-2 spike protein trimer

Xiaoli Xiong et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Add to Collection

Review Virology

Why the elderly appear to be more severely affected byCOVID-19: The potential role of immunosenescence andCMV

Seilesh Kadambari et al.

REVIEWS IN MEDICAL VIROLOGY (2020)

Add to Collection

Article Cell Biology

Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant

Petra Mlcochova et al.

CELL REPORTS MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data

Samuel L. Wolock et al.

CELL SYSTEMS (2019)

Add to Collection

Article Multidisciplinary Sciences

Excessive CD11c+Tbet+ B cells promote aberrant TFH differentiation and affinity-based germinal center selection in lupus

Wenqian Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Add to Collection

Review Immunology

Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations

Ignacio Sanz et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

The Immune Epitope Database (IEDB): 2018 update

Randi Vita et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Multidisciplinary Sciences

From Louvain to Leiden: guaranteeing well-connected communities

V. A. Traag et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Multidisciplinary Sciences

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE

Shu Wang et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Medicine, Research & Experimental

Circulating and intrahepatic antiviral B cells are defective in hepatitis B

Alice R. Burton et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

SCANPY: large-scale single-cell gene expression data analysis

F. Alexander Wolf et al.

GENOME BIOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Early derivation of IgM memory cells and bone marrow plasmablasts

Amber M. Papillion et al.

PLOS ONE (2017)

Add to Collection

Article Microbiology

Malaria-induced interferon-γ drives the expansion of Tbet hi atypical memory B cells

Nyamekye Obeng-Adjei et al.

PLOS PATHOGENS (2017)

Add to Collection

Review Immunology

Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection

Shahzma Merani et al.

FRONTIERS IN IMMUNOLOGY (2017)

Add to Collection

Review Immunology

Follicular Helper T Cells

Carola G. Vinuesa et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)

Add to Collection

Article Infectious Diseases

B cell sub-types following acute malaria and associations with clinical immunity

Richard T. Sullivan et al.

MALARIA JOURNAL (2016)

Add to Collection

Article Biology

Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function

Silvia Portugal et al.

ELIFE (2015)

Add to Collection

Article Hematology

Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity

Anatoly V. Rubtsov et al.

BLOOD (2011)

Add to Collection

Article Hematology

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

Cyril Fauriat et al.

BLOOD (2010)

Add to Collection

Article Immunology

Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults

Sebastian Seidler et al.

BMC IMMUNOLOGY (2010)

Add to Collection

Article Immunology

CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection

Rachael Racine et al.

JOURNAL OF IMMUNOLOGY (2008)

Add to Collection

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.